Wilson Sonsini Goodrich & Rosati advised Aytu BioPharma on the transaction.Aytu BioPharma, Inc. (the “Company” or “Aytu”) (Nasdaq:AYTU) and Lupin Pharma Canada Ltd (“Lupin”), a subsidiary…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
